ArticleArthritis & rheumatology (Hoboken, N.J.)2019

Excess Deaths Upon Cessation of Xanthine Oxidase Inhibitor Treatment-Data From the Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Morbidities Trial: Comment on the Article by Choi et al.

Michael R BubbPubMed ↗Publisher ↗

No numbers read from the abstract.